Istari Oncology, Inc., a clinical-stage biotechnology company focused on novel immunotherapies for the treatment of solid tumors, today announced the company will participate in the following two virtual investment conferences taking place in September 2021:

Event: Morgan Stanley’s 19^th Annual Global Healthcare Conference

Speaker: Executive leadership, Istari Oncology

Session Date/Time: Tuesday, September 14, 2021, from 5:00 - 5:30 p.m. EDT

Format: Fireside chat

Registration: Interested parties can attend the live webcast of Istari’s fireside chat here. The webcast will also be archived on www.istarioncology.com.

Event: H.C. Wainwright 23^rd Annual Global Investment Conference

Speaker: Garrett Nichols, CMO, Istari Oncology

Session Date/Time: Available on-demand from September 13-15, 2021, beginning at 7:00 a.m. EDT

Format: Company presentation

Registration: Institutional investors can register for the conference and view Istari’s on-demand presentation here.

About Istari Oncology

Istari Oncology, Inc., headquartered in Research Triangle Park, North Carolina, is a privately held clinical-stage biotechnology company focused on novel immunotherapies for the treatment of glioblastoma and a wide variety of solid tumors. Istari has licensed a broad range of patents and patent applications and has access to additional intellectual property to continue clinical and commercial development of these technologies. The company’s primary asset currently in clinical development is PVSRIPO. For more information, please visit: www.istarioncology.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005222/en/